Carolyn L Weeks-Levy

Title: The Innovative Contributions of Carolyn L Weeks-Levy

Introduction

Carolyn L Weeks-Levy is a prominent inventor based in Valhalla, NY (US). She has made significant contributions to the field of virology, particularly in the development of methods for producing RNA viruses. With a total of 6 patents to her name, her work has had a profound impact on vaccine development and infectious disease research.

Latest Patents

One of her latest patents is titled "Method for producing RNA viruses from cDNA." This invention relates to methods for producing viable RNA viruses from cDNA, as well as novel RNA virus cDNA and recombinant DNA molecules. The invention also includes methods for screening variants of a strain 3 poliovirus and increasing the attenuation of a strain poliovirus. Furthermore, it provides a vaccine useful for immunizing subjects against infectious poliovirus, which comprises an effective amount of an RNA virus produced through specific recombinant nucleic acid sequences. Another notable patent is "Replication-competent recombinant viral vaccines and method of producing." This patent focuses on replication-competent recombinant viruses, particularly polioviruses, which include exogenous nucleic acid sequences and artificial proteolytic cleavage sites. These recombinant viruses are useful as vaccines against various infections and diseases.

Career Highlights

Throughout her career, Carolyn has worked with esteemed institutions such as Columbia University and the Whitehead Institute for Biomedical Research. Her research has contributed to advancements in vaccine technology and the understanding of viral mechanisms.

Collaborations

Carolyn has collaborated with notable colleagues in her field, including Vincent Racaniello and Joanne Marie Tatem. These collaborations have further enhanced her research and contributions to virology.

Conclusion

Carolyn L Weeks-Levy's innovative work in the field of virology has led to significant advancements in vaccine development and infectious disease research. Her contributions continue to influence the scientific community and improve public health outcomes.